ID   KHM-4
AC   CVCL_9545
SY   KHM4
DR   CGH-DB; 9160-4
DR   Wikidata; Q54899905
RX   PubMed=1611184;
RX   PubMed=10936422;
RX   PubMed=15215163;
CC   Population: Japanese.
CC   Characteristics: Produces IgA kappa.
CC   Omics: Variations; Array-based CGH.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   51Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 10-04-25; Version: 16
//
RX   PubMed=1611184; DOI=10.2169/internalmedicine.31.339;
RA   Matsuzaki H., Matsuno F., Yoshida M., Hata H., Okazaki K.,
RA   Takatsuki K.;
RT   "Human myeloma cell line (KHM-4) established from a patient with
RT   multiple myeloma associated with hyperammonemia.";
RL   Intern. Med. 31:339-343(1992).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//
RX   PubMed=15215163; DOI=10.1016/S0002-9440(10)63276-2; PMCID=PMC1618545;
RA   Inoue J., Otsuki T., Hirasawa A., Imoto I., Matsuo Y., Shimizu S.,
RA   Taniwaki M., Inazawa J.;
RT   "Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be
RT   associated with drug-resistance phenotype in multiple myeloma.";
RL   Am. J. Pathol. 165:71-81(2004).
//